Children with Nontraumatic Back Pain and No Red Flags May Not Need Imaging

Article

Imaging children with nontraumatic back pain need not be routine practice.

Imaging is likely not indicated among children who present with nontraumatic back pain without evidence of clinical red flags, according to an article published in the Journal of the American College of Radiology.  The Expert Panel on Pediatric Imaging draws up evidence-based guidelines and makes recommendations regarding the appropriateness of imaging and treatment procedures for specific clinical scenarios. In this case, using the American College of Radiology Appropriateness Criteria, the panel determined a more conservative approach be taken when assessing a child presenting with isolated back pain who does not have any clinical red flags. However, imaging should be considered for children with back pain who have or complain of the following: • Constant pain, night pain, and radicular pain, alone or in combination, lasting for 4 weeks or more; • Abnormal neurologic examination; or • Clinical and laboratory findings suggesting an infectious or neoplastic etiology. When imaging is appropriate, initial imaging should consist of spine radiographs limited to area of interest, with spine MRI without contrast to evaluate further, if needed. CT of the spine, limited to area of interest, and Tc-99m bone scan whole body with single-photon emission computed tomography may be useful in some patients. The addition of intravenous contrast is also recommended for evaluation of a potential neoplastic or infectious process. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment. 

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.